Alexanders INC

Market Movers (8-K)

NYSE
Alexander's, Inc. has finalized the sale of its Rego Park I shopping center in Queens to Northwell Health for $235.5 million.
NYSE
Alexanders, Inc. stockholders approved the 2026 Omnibus Stock Plan and re-elected three directors at the annual meeting, with strong support for executive compensation and auditor ratification.
NYSE
Alexanders Inc. subsidiary 731 Office One LLC amended its lease with Bloomberg L.P., providing a $56.8 million rent abatement offset by a reduction in Bloomberg's tenant improvement fund, and simultaneously adjusted its loan agreement to establish a free rent reserve account.
NYSE
Alexanders, Inc. has successfully restructured its $300 million mortgage loan on the 731 Lexington Avenue retail condominium, extending its maturity to December 2035.
NYSE
Alexanders, Inc. has completed a $175 million refinancing of its Rego Park II shopping center, extending its loan maturity to December 2030.
NYSE
Alexanders Inc. successfully held its 2025 Annual Meeting of Stockholders, reelecting two directors and ratifying its independent auditor.

Quarterly Earnings (10-Q)

NYSE
Alexanders Inc. announced a significant surge in net income for Q2 2026, primarily due to a substantial gain from the sale of its Rego Park I property, while maintaining stable rental revenues.
Better than expected
NYSE
Alexanders Inc. reported a significant decrease in net income for the first quarter of 2026 compared to the prior year, primarily due to lower rental revenues and increased operating expenses, while also progressing with the sale of its Rego Park I shopping center.
Worse than expected
NYSE
Alexanders Inc. reported a decline in net income and rental revenues for the nine months ended September 30, 2025, and is in discussions to restructure a $300 million mortgage loan that was not repaid on its extended maturity date.
Delay expected
Worse than expected
NYSE
Alexanders Inc. reported a significant decline in net income and FFO for Q2 2025, primarily due to major tenant lease expirations and lower interest income.
Delay expected
Worse than expected
NYSE
Alexanders Inc.'s Q1 2025 net income decreased to $12.3 million, or $2.40 per diluted share, compared to $16.1 million, or $3.14 per diluted share, in the prior year, primarily due to lease expirations.
Worse than expected
NYSE
Alexanders Inc. reports a decrease in net income for the third quarter of 2024, alongside updates on lease extensions and financing activities.
Worse than expected

Annual Reports (10-K)

NYSE
Alexander's, Inc. reported a significant decline in net income and FFO for 2025, driven by major lease expirations and retail vacancies, despite a debt restructuring and key tenant lease extension.
Worse than expected
Capital raise
NYSE
Alexanders Inc.'s 2024 annual report reveals a decrease in net income despite revenue growth, influenced by strategic leasing activities and evolving market dynamics in New York City's real estate sector.
Worse than expected
NYSE
Alexanders Inc.'s annual 10-K filing outlines the company's capital structure, restrictions on stock ownership to maintain REIT status, and various operational and financial risks.
Worse than expected

Insider Trading (Form 4)

NYSE
Director Wendy Silverstein was granted 505 deferred stock units by Alexander's, Inc. on May 21, 2026.
NYSE
Director Arthur Sonnenblick was granted 505 deferred stock units in Alexander's, Inc. as part of his compensation.
NYSE
Director Mandakini Puri was granted 505 deferred stock units by Alexander's, Inc. on May 21, 2026.
NYSE
Director Thomas R. DiBenedetto was granted 505 Deferred Stock Units by Alexander's, Inc. on May 21, 2026.
NYSE
Director Russell B. Wight Jr. was granted 505 deferred stock units in Alexander's, Inc. as part of a routine equity compensation.
NYSE
Director David Mandelbaum was granted 505 Deferred Stock Units of Alexander's, Inc. on May 21, 2026.

Proxy Statements (Def-14A)

NYSE
Alexanders, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, a new stock plan, executive compensation, and auditor ratification.
NYSE
Alexanders, Inc. announces its 2025 Annual Meeting of Stockholders to be held on May 22, 2025, and provides information on how stockholders can access proxy materials and vote.
NYSE
Alexanders, Inc. will hold its 2025 Annual Meeting of Stockholders virtually on May 22, 2025, to elect directors and ratify the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm.
NYSE
Alexanders, Inc. announces its 2024 Annual Meeting of Stockholders to be held on May 23, 2024, and provides instructions for voting on key proposals.
NYSE
Alexanders, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on May 23, 2024, to elect directors and ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm.

Schedule 13G - Passive Investments

NYSE
Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC reported a 2.9% beneficial ownership in Alexanders Inc. common stock as of December 31, 2025.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting its beneficial ownership in Alexander's Inc has fallen to 3.90% following an internal realignment.